知镜 Cognispect · 医学文献与研究工作台

IgA nephropathy: gut microbiome insights and unmet needs in pediatrics.

Zhou Z, Zhang C, Yin L.
Pediatric nephrology (Berlin, Germany) · 2026-10-26 · PMID 42931891

文献摘要

Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulopathy worldwide and a leading cause of chronic kidney disease and kidney failure in children and young adults. Well-established pathogenic pathways include genetic susceptibility, intrinsic B-cell glycosylation abnormalities, complement activation, and immune dysregulation, and accumulating evidence further places the gut microbiome at the center of IgAN pathogenesis via the gut-kidney axis. A critical evidence gap defines the field: no prospective cohort has characterized the gut microbiome in pediatric primary IgAN. This conceptual narrative review synthesizes well-validated mechanistic data from adult cohorts-most notably microbial-mediated IgA1 deglycosylation-and extrapolates these findings to pediatric populations through the lens of the developmental entanglement framework, which accounts for the synchronized maturation of the gut microbiome, mucosal immunity, and renal structure in early life. Using an adapted Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, we separately rate evidence quality for adult and pediatric populations, explicitly mark all pediatric extrapolations as unvalidated, and cautiously appraise indirect evidence from pediatric IgA vasculitis with nephritis (IgAVN). We further evaluate the translational potential of microbiome-guided strategies, and conclude with a pragmatic, stepwise research agenda centered on foundational cohort studies and emerging technologies to address the evidence gap. Closing this deficit will enable the development of non-invasive biomarkers and safe, mechanism-targeted therapies to prevent progressive renal failure in children with IgAN.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。